Sort
39,280 grants matching “leukemia”
Mapping Transport Pathways through Nuclear Pores using 3D Super-Resolution Microscopy
$314,499Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2024 · GM
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
$314,497Dartmouth College · R01 · FY2003 · CA
Project 2 - IMiD Resistance in Patients and Humanized Mice with Multiple Myeloma
$314,462Shaji Kunnathu Kumar · Mayo Clinic Arizona · U54 · FY2021 · CA
MOLECULAR FUNCTION OF FANCONI ANEMIA GENES
$314,458Oregon Health And Science University · P01 · FY2000 · HL
c-Myc Phosphorylation Sites Regulate Its Apoptotic and Tumorigenic Potential
$314,449Rosalie C Sears · Oregon Health & Science University · R01 · FY2010 · CA
c-Myc Phosphorylation Sites Regulate Its Apoptotic and Tumorigenic Potential
$314,449Rosalie C Sears · Oregon Health & Science University · R01 · FY2008 · CA
c-Myc Phosphorylation Sites Regulate Its Apoptotic and Tumorigenic Potential
$314,449Rosalie C Sears · Oregon Health & Science University · R01 · FY2009 · CA
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
$314,448Lee M Graves · Univ Of North Carolina Chapel Hill · R01 · FY2023 · GM
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
$314,448Lee M Graves · Univ Of North Carolina Chapel Hill · R01 · FY2020 · GM
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
$314,448Lee M Graves · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
$314,448Lee M Graves · Univ Of North Carolina Chapel Hill · R01 · FY2021 · GM
Novel Functions of Red Cell Proteins Lu and LW
$314,429Joel A Chasis · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2008 · DK
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
$314,418David L Lampi Hermanson · Research And Diagnostic Systems, Inc. · R44 · FY2020 · CA
MIXED CHIMERISM FOLLOWING BMT FOR HEMATOLOGIC MALIGNANCY
$314,405Massachusetts General Hospital · R01 · FY2002 · CA
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
$314,393Thomas Jefferson University · R01 · FY2002 · CA
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
$314,393Thomas Jefferson University · R01 · FY2005 · CA
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
$314,393Thomas Jefferson University · R01 · FY2004 · CA
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
$314,393Thomas Jefferson University · R01 · FY2003 · CA
Chemically Controlled Assembly of Therapuetic Protein Nanostrctures
$314,382Carston R. Wagner · University Of Minnesota · R01 · FY2009 · CA
Targeting IL-12/23 p40 Pathways for the Control of GVHD
$314,378Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2016 · CA
Targeting IL-12/23 p40 Pathways for the Control of GVHD
$314,378Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2015 · CA
Targeting IL-12/23 p40 Pathways for the Control of GVHD
$314,378Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2017 · CA
CRLF2 signaling in B-cell acute lymphoblastic leukemia
$314,376David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL
$314,365Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2017 · CA
SOUTHWEST ONCOLOGY GROUP
$314,340Louisiana State Univ Hsc Shreveport · U10 · FY2003 · CA